Thrombophilia: A feature of importance in retinal vein thrombosis?

Acta Ophthalmologica Scandinavica

Volumn 77, Issue 6, 1999, Pages 619-621

  Ingerslev, Jørgen ^a  

^a Center for Haemophilia and Thrombosis   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

HUMAN; NOTE; PRIORITY JOURNAL; RETINA VEIN; RISK FACTOR; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0033431803     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.1999.770601.x     Document Type: Note

References (12)

1. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, Van dert Veldenn PA & Reitsma PH (1994): Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67.
2. Cattaneo M (1999): Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 81:165-176.
3. Coniglio M, Platania A, Di Nucci GD, Arcieri P, Modzrewska R & Mariani G (1996): Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusions. Thromb Res 83: 183-188.
4. Dahlbäck B, Carlsson M & Svensson PJ (1993): Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction oif a cofactor to activated protein VC. Proc Natl Acad Sci (USA) 90: 1004-1008.
5. Gaustadnes M, Rüdiger N, Møller J, Rasmussen K, Bjerregaard Larsen T & Ingerslev J (1999): Thrombophilic predisposition in stroke and venous thromboemboilism in Danish patients. Blood Coagul Fibrinol 10: 251-259.
6. Gottlieb JL, Blice JR Mestichelli B, Konkle BA & Denson WE (1998): Activated protein C resistance, factor V Leiden, and central vein occlusion in young adults. Arch Ophthalmol 116: 577-579.
7. Kalayci D, Gürgey A, Güven D, Parlak H & Hasipiri H (1999): Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion. Acta Ophthalmol Scand 77: 622-624.
8. Larsson J, Olafsdottir E & Bauer B (1996): Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 80: 200-202.
9. Linna T, Ylikorla A, Kontula K, Puska P & Tervo T (1997): Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 77: 212-224.
10. Poort SR, Rosendaal FR, Reitsma PH & Bertina RM (1996): A common genetic variant in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88: 3698-3703.
11. Rees DC, Chapman NH, Webster MT. Guerreiro JF, Rochette J & Clegg JB (1999): Born to clot: the European burden. Br J Haematol 105: 564-566.
12. Wenzler EM, Rademakers AJ, Boers GH, Cruysberg JR, Webers CA & Deutman AF (1993): Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophtalmol 115: 1162-1167.